Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases

Area of Science:

• Immunology
• Infectious Diseases
• Public Health

Background:

• Emerging and re-emerging infectious diseases pose a significant global threat, exacerbated by factors like urbanization and climate change.
• Recent outbreaks (Ebola, MERS-CoV, Zika) highlight insufficient preparedness and a lack of effective countermeasures.
• Global biopreparedness requires enhanced strategies to combat these expanding public health challenges.

Framework:

• A summit convened leaders in life sciences and biomedical R&D to address biopreparedness.
• The meeting focused on exploring challenges, inventorying capabilities, and assessing gaps in preparation and response.
• The goal was to identify actionable steps for improving global biopreparedness.

Implementation:

• The summit, held October 2-3, 2018, at the Trudeau Institute, brought together key opinion leaders.
• Proceedings focused on translational immunology to support biomedical countermeasure development.
• Discussions aimed to bridge the gap between research and effective public health interventions.

Implications:

• Improved biopreparedness is essential for national security and economic stability.
• Strengthening the development and deployment of vaccines and therapeutics is critical.
• Collaborative efforts are needed to enhance global response to future infectious disease threats.